We next evaluated if CEER could be utilized in in vivo samples to profile HER1 and HER2 in tumor tissues obtained through (Fine Needle Aspirates) FNAs from breast cancer xenografts (Table 1) with varying degrees of ErbB-RTK expression [17-19,24]. The gene discussed is ERBB2; the disease is breast carcinoma.